Is SNDX stock safe? | Glauxie AI

Q: Is SNDX stock safe?

Syndax Pharmaceuticals, Inc. (SNDX) operates in the Biotechnology industry (Healthcare sector). The company is led by CEO Michael A. Metzger. Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical... Employees: 298.

Q: What are the risks of investing in SNDX?

Identify key risks of investing in SNDX — debt, competition, volatility, and sector headwinds.

Q: Is SNDX a good long-term investment?

Evaluate SNDX as a long-term investment using fundamental scores, growth metrics, and risk assessment.

Q: How much debt does SNDX have?

Review SNDX total debt, debt-to-equity ratio, interest coverage, and leverage trends.

Is SNDX stock safe?

🦉

Syndax Pharmaceuticals, Inc. (SNDX)

Company Overview

Sector / IndustryHealthcare / Biotechnology

CEOMichael A. Metzger

Syndax Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, develops therapies for the treatment of cancer. Its lead product candidates are SNDX-5613, which is in phase 1/2 clinical trial targeting the binding interaction of Menin with the mixed lineage leukemia 1 protein for the...

Key Executives

Name	Title
Joseph Paul Eder	Member of Scientific Advisory Board & Chief Medical Officer
Keith Alan Goldan	CFO, Treasurer & Principal Accounting Officer
Kevin McManus	Chief People Officer
Luke J. Albrecht	Senior Vice President, General Counsel & Secretary
Michael A. Metzger	Chief Executive Officer & Director
Michael Downes	Co-Founder

Financial Health

Risk Assessment

Weather Score0/100

RegimeN/A

SNDX Profile Financials

What are the risks of investing in SNDX? Is SNDX a good long-term investment? How much debt does SNDX have?